Li Zhu
- Infectious Diseases top 0.1%
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 4
- Neurology top 0.2%
- Modeling and Simulation top 1%
- Obstetrics and Gynecology top 2%
-
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 6
-
- Complement system in diseases 4
-
- Liver Diseases and Immunity 4
-
- Platelet Disorders and Treatments 4
-
- Pancreatitis Pathology and Treatment 3
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Li Zhu
49 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Infectious Diseases 4.6k
- Neurology 2.4k
- Modeling and Simulation 252
- Critical Care and Intensive Care Medicine 282
- Obstetrics and Gynecology 287
Countries citing papers authored by Li Zhu
This map shows the geographic impact of Li Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhu more than expected).
Fields of papers citing papers by Li Zhu
This network shows the impact of papers produced by Li Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhu. The network helps show where Li Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 12 | |
| 11 | 2020 | 63 | |
| 12 | 2020 | 41 | |
| 13 | 2020 | 28 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 33 | |
| 16 | 2018 | 12 | |
| 17 | Application of platelet rich fibrin combined with atorvastatin in the regeneration treatment of degree II furcation involvements of mandibular molars | 2017 | 3 |
| 18 | 2013 | 14 | |
| 19 | AL-78898A Inhibits Complement Deposition in a Primate Light Damage Model | 2012 | 2 |
| 20 | An experimental study on rats brain protection of tetrandrine from dementia | 2004 | 1 |
About Li Zhu
Li Zhu is a scholar working on Hepatology, Transplantation and Epidemiology, having authored 54 papers that have together received 7.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), COVID-19 Clinical Research Studies (7 papers), Hepatitis B Virus Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Complement system in diseases (4 papers), Liver Diseases and Immunity (4 papers), Platelet Disorders and Treatments (4 papers) and Pancreatitis Pathology and Treatment (3 papers). The work is most often cited by research in Infectious Diseases (4.6k citations), Neurology (2.4k citations) and Modeling and Simulation (252 citations). Li Zhu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Changqing Bai, Zhe Xu, Hongxia Liu, Peng Xia, Yijin Wang, Jiyuan Zhang, Shuhong Liu, Jin‐Wen Song, Lei Huang and Tingting Gao. Their work appears in journals such as Blood, Hepatology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.